Katie J. Suda

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.818Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design

Drug and Alcohol Dependence Reports(2023)10.1016/j.dadr.2023.100135

Top 25%

0.818DataRank

Top 25%12 citations

Katherine Callaway Kim, Katie J. Suda, Jing Luo, Xiaoming Wang, Donna Olejniczak +2 more

Papers

Driven by 22 papers — median percentile 75. Top paper: “Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design”.

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design

Drug and Alcohol Dependence Reports(2023)10.1016/j.dadr.2023.100135

Top 25%

0.818DataRank

Top 25%12 citations

Katherine Callaway Kim, Katie J. Suda, Jing Luo, Xiaoming Wang, Donna Olejniczak +2 more

Attitudes toward using clinical decision support in community pharmacies to promote antibiotic stewardship

Journal of the American Pharmacists Association(2021)10.1016/j.japh.2021.04.008

N/A

0DataRank · unranked

13 citations

Margaret Botros, Katie J. Suda, Randi E. Foraker, Michael J. Durkin, Sena Sayood

Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic

CHEST Journal(2021)10.1016/j.chest.2021.08.007

N/A

0DataRank · unranked

7 citations

Mina Tadrous, Sandra L. Kane‐Gill, Ian J. Barbash, Scott D. Rothenberger, Katie J. Suda +1 more

Effect of the COVID-19 pandemic on adversity in individuals receiving anticoagulation for atrial fibrillation: A nationally representative administrative health claims analysis

American Heart Journal Plus Cardiology Research and Practice(2022)10.1016/j.ahjo.2022.100096

N/A

0DataRank · unranked

9 citations

Nico Gabriel, Meiqi He, Jingchuan Guo, Mina Tadrous, Katie J. Suda +2 more

Opportunities for penicillin allergy evaluation in dental clinics

Antimicrobial Stewardship & Healthcare Epidemiology(2022)10.1017/ash.2022.18

N/A

0DataRank · unranked

7 citations

Michael J. Durkin, Ibuola Kale, Taylor L. Boyer, Margaret A. Fitzpatrick, Charlesnika T. Evans +4 more

Barriers to and facilitators of opioid prescribing by dentists in the United States

The Journal of the American Dental Association(2022)10.1016/j.adaj.2022.05.009

N/A

0DataRank · unranked

5 citations

Swetha Ramanathan, Katie J. Suda, Tumader Khouja, Susan Rowan, Charlesnika T. Evans +5 more

How decisions are made: Antibiotic stewardship in dentistry

Infection Control and Hospital Epidemiology(2023)10.1017/ice.2023.173

N/A

0DataRank · unranked

17 citations

Katie J. Suda, Daphne Lew, Susan Rowan, Danny Hanna, Tracey Bach +4 more

Analysis by Gender and Race and Ethnicity of Reviewers and Awardees for Intramural Research Funding in the Veterans Health Administration

JAMA Network Open(2023)10.1001/jamanetworkopen.2022.51353

N/A

0DataRank · unranked

7 citations

Utibe R. Essien, Terrence M. A. Litam, Leslie R. M. Hausmann, Katie J. Suda, Taylor L. Boyer

Anti-hypertensive Medication Use Among People with and without Substance Use Disorders

Journal of General Internal Medicine(2023)10.1007/s11606-023-08543-3

N/A

0DataRank · unranked

1 citations

Katie J. Suda, Alyssa Halbisen, Hefei Wen, J. Frank Wharam, Ann‐Marie Rosland +2 more

A Retrospective Cohort Study of the 2018 Angiotensin Receptor Blocker (ARB) Recalls and Subsequent Drug Shortages on Patients with Hypertension

medRxiv(2023)10.1101/2023.08.17.23294250

N/A

0DataRank · unranked

1 citations

Mina Tadrous, Inmaculada Hernandez, Katherine Callaway Kim, Scott D. Rothenberger, Nandita Mukhopadhyay +3 more

Drug Shortages Prior to and During the COVID-19 Pandemic

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.4246

N/A

0DataRank · unranked

50 citations

Scott D. Rothenberger, Mina Tadrous, Inmaculada Hernandez, Walid F. Gellad, Joshua W. Devine +4 more

Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104381

N/A

0DataRank · unranked

36 citations

Katie J. Suda, Jing Luo, MyoungKeun Lee, Joel Anderton, Donna Olejniczak +2 more

A scoping review of patient safety checklists in dentistry

Clinical Oral Investigations(2024)10.1007/s00784-024-05996-6

N/A

0DataRank · unranked

9 citations

Thomas J. Miner, Muhammad F. Walji, Elsbeth Kalenderian, D. Brad Rindal, Katie J. Suda +1 more

Barriers and facilitators to guideline concordant dental antibiotic prescribing in the United States: A qualitative study of the National Dental PBRN

Journal of Public Health Dentistry(2024)10.1111/jphd.12611

N/A

0DataRank · unranked

6 citations

Connie H. Yan, Katie J. Suda, Charlesnika T. Evans, Tumader Khouja, Ronald C. Hershow +5 more

Ceftazidime/avibactam alone or in combination with an aminoglycoside for treatment of carbapenem-resistant Enterobacterales infections: A retrospective cohort study

International Journal of Antimicrobial Agents(2024)10.1016/j.ijantimicag.2024.107321

N/A

0DataRank · unranked

5 citations

Lishan Cao, Brooke N Curry, Mark Biagi, Amanda Vivo, Katie J. Suda +2 more

Changes in Buprenorphine Prescribing After X-Waiver Exemptions: An Interrupted Time Series Analysis

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110167

N/A

0DataRank · unranked

0 citations

Katie J. Suda, Jing Luo, MyoungKeun Lee, Joel Anderton, Donna Olejniczak +2 more

Medication prescribing checklists and their impact on patient safety: A scoping review

Journal of the American Pharmacists Association(2025)10.1016/j.japh.2025.102472

N/A

0DataRank · unranked

3 citations

Tate W. Miner, Kawtar Zouaidi, Anika N. Roy, Muhammad F. Walji, Kristin N. Ray +4 more

Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder

Addiction(2025)10.1111/add.70288

N/A

0DataRank · unranked

1 citations

Ryan Colvin, Katelin B. Nickel, Rachael K. Ross, Michael J. Durkin, Katie J. Suda +3 more

High-risk medications in pediatric dentistry

The Journal of the American Dental Association(2025)10.1016/j.adaj.2025.08.007

N/A

0DataRank · unranked

0 citations

Kawtar Zouaidi, Colin C. Hubbard, Muhammad F. Walji, Matthew Cooke, D. Brad Rindal +4 more

Trends in Initiation of Buprenorphine for Opioid Use Disorder Among Older Adults

Journal of the American Geriatrics Society(2025)10.1111/jgs.70182

N/A

0DataRank · unranked

0 citations

Roisin Sabol, Bryant Shuey, Payel Roy, Katie J. Suda, Tae Woo Park +2 more

Optimal Urine Culture Diagnostic Stewardship Practice—Results from an Expert Modified-Delphi Procedure

Clinical Infectious Diseases(2021)10.1093/cid/ciab987

N/A

0DataRank · unranked

72 citations

Barbara W. Trautner, Surbhi Leekha, Kelly Coffey, Christopher J. Crnich, Daniel J. Diekema +14 more

Adherence, Switches, and Drug Spending After Angiotensin Receptor Blocker Recalls and Shortages

JAMA Health Forum(2025)10.1001/jamahealthforum.2025.4078

N/A

0DataRank · unranked

0 citations

Eric T. Roberts, Julie M. Donohue, Lindsay M. Sabik, Chester B. Good, Joshua W. Devine +3 more

Katie J. Suda

Indexed papers

Top data-sharing exemplar

Papers